156 results
Page 4 of 8
6-K
EX-99.1
tfo09oe3w g8qh
14 Feb 20
Acasti Pharma Provides Business Update for the Third Quarter of Fiscal 2020
8:00am
6-K
EX-99.1
w93fdpqvwav et67
14 Feb 20
Current report (foreign)
8:00am
6-K
EX-99.1
et5crd8 1kwjky6uo4b3
13 Feb 20
Acasti Pharma Schedules Third Quarter Fiscal 2020 and Business Update Conference Call
9:00am
6-K
EX-99.1
jpmjp nm202
10 Feb 20
Acasti Pharma Provides Update on TRILOGY 1 and TRILOGY 2 Phase 3 Trials of CaPre
7:00am
6-K
EX-99.1
n9ss9nci ghdn
13 Jan 20
Acasti Pharma Reports Topline Results for TRILOGY 1 Phase 3 Trial of CaPre
6:21am
6-K
EX-99.1
nt1t7 utpx
23 Dec 19
Acasti Pharma Provides Update on Timing of Topline Results for TRILOGY 1 Phase 3 Trial of CaPre
8:43pm
6-K
EX-99.1
3vud5
26 Nov 19
Acasti Pharma Reports Last Patient Visit in TRILOGY 1 Phase 3 Trial of CaPre for the Treatment of Severe Hypertriglyceridemia
7:58am
6-K
EX-99.1
gnkadgf9dtrs5e
18 Nov 19
Current report (foreign)
8:46am
6-K
EX-99.1
ys0irqytwx0a
13 Nov 19
Current report (foreign)
7:55am
6-K
EX-99.1
ejlu5j
13 Nov 19
Acasti Pharma Provides Business Update for the Second Quarter of Fiscal 2020
7:55am
6-K
EX-99.1
h42zwm
7 Nov 19
Acasti Pharma Announces Publication of CaPre Pharmacokinetics Study in a Leading Peer-Reviewed Journal
8:42am
6-K
EX-99.1
iyzv8 doo7mxjd64
6 Nov 19
Acasti Pharma Schedules Second Quarter Fiscal 2020 Conference Call
9:39am
6-K
EX-99.1
axe5nvanlzt
4 Nov 19
Agreement provides Acasti long-term supply of raw krill oil through commercialization
9:24am
6-K
EX-99.1
ojxqohrs0py6dwdyl5mm
1 Oct 19
Acasti Pharma to Present at the 2019 Cantor Fitzgerald Global Healthcare Conference
9:00am
6-K
EX-99.1
riop5g
30 Sep 19
Nearly 80% of randomized patients have completed the studies
8:37am
6-K
EX-99.1
jgtgl3j8t1o iojfyb
9 Sep 19
Acasti Pharma Receives Funding from the Government of Canada to Expand Production Capacity
8:41am
6-K
EX-99.1
88cj vaqn1
4 Sep 19
Acasti Pharma to Present at the 21st Annual Rodman & Renshaw Global Investment Conference in New York City on September 9th
9:00am
6-K
EX-99.1
3vt0llen807fybyzrft
28 Aug 19
Current report (foreign)
4:05pm
6-K
EX-99.1
layofecznmirmw8
14 Aug 19
Acasti Pharma Provides Business Update for the First Quarter of Fiscal 2020
12:00am
6-K
EX-99.1
uzoxn1yx819oxu3c
14 Aug 19
Current report (foreign)
12:00am